


|
|
|
Insider Transactions
| Date |
Name |
Title |
Type |
Shares Traded |
Price Range |
| Feb 19, 2013 |
Lewis, Earl R. |
Director |
Option Execute |
27,500 |
3.72 |
| Jan 14, 2013 |
luscinski susan m |
Officer |
Disposition (Non Open Market) |
11,475 |
4.38 |
| Dec 21, 2012 |
Green, David |
Officer |
Sell |
14,409 |
4.06 |
| Dec 21, 2012 |
Green, David |
Officer |
Option Execute |
14,409 |
3.16 |
| Dec 20, 2012 |
Green, David |
Officer |
Sell |
73,591 |
4.05 |
| Dec 20, 2012 |
Green, David |
Officer |
Option Execute |
73,591 |
3.16 |
| Dec 19, 2012 |
Green, David |
Officer |
Sell |
48,146 |
4.04 |
| Dec 19, 2012 |
Green, David |
Officer |
Option Execute |
48,146 |
3.16 |
| Dec 18, 2012 |
Green, David |
Officer |
Sell |
14,300 |
4.08 |
| Dec 18, 2012 |
Green, David |
Officer |
Option Execute |
45,946 |
3.16 |
| Dec 17, 2012 |
Green, David |
Officer |
Sell |
17,908 |
4.10 |
| Dec 17, 2012 |
Green, David |
Officer |
Option Execute |
17,908 |
3.16 |
| Dec 11, 2012 |
graziano chane |
Officer |
Option Execute |
200,000 |
3.48 |
| Dec 11, 2012 |
luscinski susan m |
Officer |
Option Execute |
100,000 |
3.16 |
| Jun 1, 2012 |
dishman robert a |
Director |
Acquisition (Non Open Market) |
8,403 |
n/a |
| Jun 1, 2012 |
graziano chane |
Officer |
Acquisition (Non Open Market) |
105,042 |
n/a |
| Jun 1, 2012 |
Green, David |
Officer |
Acquisition (Non Open Market) |
88,737 |
n/a |
| Jun 1, 2012 |
harte neal j |
Director |
Acquisition (Non Open Market) |
8,403 |
n/a |
| Jun 1, 2012 |
kennedy john f |
Director |
Acquisition (Non Open Market) |
8,403 |
n/a |
| Jun 1, 2012 |
Lewis, Earl R. |
Director |
Acquisition (Non Open Market) |
8,403 |
n/a |
|
|
Stock transaction information provided by EDGAR Online. Harvard Bioscience, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.
Disclaimer:
The information contained within this and other Harvard Bioscience Web pages should be deemed accurate and current as of the date of the most recent update, or if no update information has been provided, the date of issuance. Harvard Bioscience assumes no responsibility for any misincurrances or misstatements which occur as the result of the reading of dated material. Users are strongly encouraged to check dates of issuance and most recent update of any information contained within, or linked to, Harvard Bioscience’s web site. For Harvard Bioscience’s most current information please reference Harvard Bioscience public filings with the Securities and Exchange Commission located at http://www.sec.gov.
|
|
|